Citadel Advisors - PERNIX THERAPEUTICS HLDGS IN ownership

Quarter-by-quarter ownership
Citadel Advisors ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q2 2016$14,000
-41.7%
31,700
+286.6%
0.00%
Q4 2015$24,000
+200.0%
8,200
+228.0%
0.00%
Q3 2015$8,000
-73.3%
2,500
-50.0%
0.00%
Q2 2015$30,000
-82.1%
5,000
-68.2%
0.00%
Q1 2015$168,000
+14.3%
15,7000.0%0.00%
Q4 2014$147,000
+1533.3%
15,700
+1208.3%
0.00%
Q3 2014$9,000
+28.6%
1,200
+50.0%
0.00%
Q2 2014$7,0008000.00%
Other shareholders

There were no reported owners of PERNIX THERAPEUTICS HLDGS IN in Q1 2016.

NameSharesValueWeighting ↓
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders